Market Cap 409.16M
Revenue (ttm) 742.90M
Net Income (ttm) 52.60M
EPS (ttm) N/A
PE Ratio 8.21
Forward PE N/A
Profit Margin 7.08%
Debt to Equity Ratio 1.10
Volume 935,700
Avg Vol 741,644
Day's Range N/A - N/A
Shares Out 51.60M
Stochastic %K 44%
Beta 2.33
Analysts Strong Sell
Price Target $12.00

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botul...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Fax: 240 631 3203
Address:
300 Professional Drive, Suite 400, Gaithersburg, United States
Ithaca2018
Ithaca2018 Jun. 5 at 2:29 AM
$EBS Those high 7's were a very good buy if you ask me. I added. GO EBS💫
0 · Reply
alwayzwong
alwayzwong Jun. 4 at 9:46 PM
$EBS needs confirmation of move mañana….
0 · Reply
mickley32
mickley32 Jun. 4 at 8:20 PM
$EBS Good volume, increased the watch list.
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 7:23 PM
$EBS High schmetta cOOvering of first goy-p.
0 · Reply
Ithaca2018
Ithaca2018 Jun. 4 at 3:09 PM
$EBS Glad I loaded the boat yesterday;-) 💫💫💫
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:56 PM
Tartaglia, Lievonen, Kalnin. three former Sanofi executives surrounding this platform. if there's a moment to activate that network, June 12 CEPI deadline is it. $BVAXF $MRK $AEMD $EBS $REGN
1 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:55 PM
BioVaxys has DPX platform, NIH preclinical data, and a letter of support from Canadian health authorities for the CEPI submission. the foundation is there. $BVAXF $MRK $AEMD $EBS $REGN https://x.com/CEPIvaccines/status/2061845354195177962
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:54 PM
CEPI fast-tracked IAVI, Moderna and Oxford on June 1 through existing relationships. BioVaxys submitting to the open call on June 12. different track, still a real opportunity. $BVAXF $MRK $AEMD $EBS $REGN https://cepi.net/calls-for-proposals
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 2:23 PM
$EBS high schmetta
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 1:15 PM
$EBS Waterman finally updates his model: still a "BUY" at $12. https://www.streetinsider.com/Analyst+Comments/Benchmark+Reiterates+Buy+Rating+on+Emergent+BioSolutions+%28EBS%29/26588265.html
0 · Reply
Latest News on EBS
Emergent BioSolutions Earnings Call Transcript: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 5 weeks ago

Emergent BioSolutions Earnings Call Transcript: Q1 2026


Emergent BioSolutions Earnings release: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 5 weeks ago

Emergent BioSolutions Earnings release: Q1 2026


Emergent BioSolutions Slides: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 5 weeks ago

Emergent BioSolutions Slides: Q1 2026


Emergent BioSolutions Quarterly report: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 5 weeks ago

Emergent BioSolutions Quarterly report: Q1 2026


Emergent BioSolutions Transcript: AGM 2026

Apr 29, 2026, 9:00 AM EDT - 5 weeks ago

Emergent BioSolutions Transcript: AGM 2026


Emergent BioSolutions Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 6 weeks ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

Mar 17, 2026, 12:49 PM EDT - 2 months ago

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

SIGA


Emergent BioSolutions appoints Fowler to board of directors

2026-03-03T13:40:58.000Z - 3 months ago

Emergent BioSolutions appoints Fowler to board of directors


Emergent BioSolutions appoints Fowler to board of directors

2026-03-03T13:27:16.000Z - 3 months ago

Emergent BioSolutions appoints Fowler to board of directors


Emergent BioSolutions reports Q4 EPS (43c) vs. 5c last year

2026-02-26T22:40:37.000Z - 3 months ago

Emergent BioSolutions reports Q4 EPS (43c) vs. 5c last year


Emergent BioSolutions authorizes $50M stock repurchase program

2026-02-26T22:30:21.000Z - 3 months ago

Emergent BioSolutions authorizes $50M stock repurchase program


Emergent BioSolutions Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Emergent BioSolutions Earnings Call Transcript: Q4 2025


Emergent BioSolutions Annual report: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Emergent BioSolutions Annual report: Q4 2025


Emergent BioSolutions Earnings release: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Emergent BioSolutions Earnings release: Q4 2025


Emergent BioSolutions Slides: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Emergent BioSolutions Slides: Q4 2025


Emergent BioSolutions gets FDA approval of sNDA for Narcan

2026-02-12T23:05:22.000Z - 4 months ago

Emergent BioSolutions gets FDA approval of sNDA for Narcan


Emergent BioSolutions Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

Emergent BioSolutions Earnings Call Transcript: Q3 2025


Emergent BioSolutions Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

Emergent BioSolutions Quarterly report: Q3 2025


Emergent BioSolutions Earnings release: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

Emergent BioSolutions Earnings release: Q3 2025


Emergent BioSolutions Slides: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

Emergent BioSolutions Slides: Q3 2025


Emergent BioSolutions Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Emergent BioSolutions Earnings Call Transcript: Q2 2025


Emergent BioSolutions Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Emergent BioSolutions Quarterly report: Q2 2025


Emergent BioSolutions Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Emergent BioSolutions Earnings release: Q2 2025


Emergent BioSolutions Slides: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Emergent BioSolutions Slides: Q2 2025


Ithaca2018
Ithaca2018 Jun. 5 at 2:29 AM
$EBS Those high 7's were a very good buy if you ask me. I added. GO EBS💫
0 · Reply
alwayzwong
alwayzwong Jun. 4 at 9:46 PM
$EBS needs confirmation of move mañana….
0 · Reply
mickley32
mickley32 Jun. 4 at 8:20 PM
$EBS Good volume, increased the watch list.
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 7:23 PM
$EBS High schmetta cOOvering of first goy-p.
0 · Reply
Ithaca2018
Ithaca2018 Jun. 4 at 3:09 PM
$EBS Glad I loaded the boat yesterday;-) 💫💫💫
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:56 PM
Tartaglia, Lievonen, Kalnin. three former Sanofi executives surrounding this platform. if there's a moment to activate that network, June 12 CEPI deadline is it. $BVAXF $MRK $AEMD $EBS $REGN
1 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:55 PM
BioVaxys has DPX platform, NIH preclinical data, and a letter of support from Canadian health authorities for the CEPI submission. the foundation is there. $BVAXF $MRK $AEMD $EBS $REGN https://x.com/CEPIvaccines/status/2061845354195177962
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 4 at 2:54 PM
CEPI fast-tracked IAVI, Moderna and Oxford on June 1 through existing relationships. BioVaxys submitting to the open call on June 12. different track, still a real opportunity. $BVAXF $MRK $AEMD $EBS $REGN https://cepi.net/calls-for-proposals
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 2:23 PM
$EBS high schmetta
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 1:15 PM
$EBS Waterman finally updates his model: still a "BUY" at $12. https://www.streetinsider.com/Analyst+Comments/Benchmark+Reiterates+Buy+Rating+on+Emergent+BioSolutions+%28EBS%29/26588265.html
0 · Reply
IntelligunInvestings
IntelligunInvestings Jun. 4 at 9:42 AM
$EBS buying tomorrow if this drops
0 · Reply
alwayzwong
alwayzwong Jun. 4 at 2:01 AM
$EBS depression
1 · Reply
ComradeKomisar
ComradeKomisar Jun. 4 at 1:12 AM
$EBS I hear it is customary for "dark pools" to short 80% of the day's volume when presentations are made. That, and "sell in May, and go away"
2 · Reply
alwayzwong
alwayzwong Jun. 4 at 12:09 AM
$EBS wat min?
0 · Reply
Daniel3303
Daniel3303 Jun. 3 at 10:27 PM
$EBS The drop is 100% a short attack, adding tomorrow
1 · Reply
KnuckleSandwich
KnuckleSandwich Jun. 3 at 7:57 PM
$EBS did Papa just buy 100K shares at 7.75-7.85??
0 · Reply
alwayzwong
alwayzwong Jun. 3 at 6:00 PM
$EBS company is stable, we need a revenue generator ASAP.
2 · Reply
KnuckleSandwich
KnuckleSandwich Jun. 3 at 5:50 PM
$EBS Despite all metrics outperforming no real wallstreet money is watching EBS.. until we get more analyst coverage or a catalyst like another 10 year long term contract award it will be difficult for EBS to move up... Papa needs to turn up the volume!
1 · Reply
Antioch_Capital
Antioch_Capital Jun. 3 at 5:46 PM
$EBS Buying back shares NOW at this price appears to be a good allocation of Capital -JP 🤙🏻
0 · Reply
Antioch_Capital
Antioch_Capital Jun. 3 at 5:44 PM
$EBS Growth initiative for deliberate International expansion confirmed for the 3rd time today. 👏
0 · Reply
KnuckleSandwich
KnuckleSandwich Jun. 3 at 5:40 PM
$EBS hoping the Jefferies presentation can get us additional analyst coverage and upgrades!
0 · Reply
KnuckleSandwich
KnuckleSandwich Jun. 3 at 5:38 PM
$EBS Ceo Papa is very optimistic about the guidance for 2026. Firing on all cylinders for financial improvements!
0 · Reply